http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015026292-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbaced0995cda76fea038c684318a8fe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_472d3c45ea680ba1054fbd6343f079fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6efb81a92d89531f5ac561b6a8f7efab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13b5566bce5085c068a395e58cf8ef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad5a5223af363d8443bc3db4e9f37b83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c5dcedf6234f18ffd5d8e09414db850
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fee431ce2ca598234415ae6ff64dd2b
publicationDate 2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112015026292-B1
titleOfInvention USE OF 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOLE-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN -2(1H)- ONA AND IN VITRO METHODS
abstract dihydropyrazine-pyrazine compound, pharmaceutical composition comprising it, use of the compound, methods for inhibiting or measuring phosphorylation and for inhibiting dna-pk activity, as well as kit. [001] The present invention relates to methods of treating or preventing chronic lymphocytic leukemia, comprising administering an effective amount of a dihydropyrazine-pyrazine compound to a patient with chronic lymphocytic leukemia.
priorityDate 2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420222241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58298318

Total number of triples: 24.